Journal of Nuclear Medicine September 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145 ...
Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11 C]UCB-J PET ...
Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267736; DOI: https://doi.org/10.2967/jnumed.124.267736 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267964; DOI: https://doi.org/10.2967/jnumed.124.267964 ...
Journal of Nuclear Medicine September 2024, jnumed.123.267215; DOI: https://doi.org/10.2967/jnumed.123.267215 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267578; DOI: https://doi.org/10.2967/jnumed.124.267578 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...
Journal of Nuclear Medicine September 2024, jnumed.123.267274; DOI: https://doi.org/10.2967/jnumed.123.267274 ...
Nuclear medicine for therapeutic purposes, here termed molecular radiotherapy (MRT), is a rapidly developing field, mostly in the context of metastatic cancer treatment. It is self-evident that ...
FINDing the radiopharma future: Behrenbruch provides perspective on the effects of radiopharmaceutical regulatory reforms and highlights the potential of the Facilitating Innovative Nuclear ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...